Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 3/6/24 → 11/18/26 |
Funding
- Amylyx Pharmaceuticals Incorporated: $96,679.00
A Phase 3 Study of Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION) - A35-009
- Slevin, John (PI)